Glaukos Corporation Share Price
NASDAQ: GKOSHealthcare
Live Glaukos Corporation Share Price Chart
O H L
Glaukos Corporation Performance Overview
Days Range
▼
$161.35Low
$162.57High
Markets Today
| Previous Close | $161.42 |
|---|---|
| Open | $161.36 |
| Volume | 94,671 |
| Day's Range | $161.35 - $162.57 |
| 52W Range | $73.16 - $191.62 |
| Market Cap | $9.64 B |
Historical Performance
| 1M Returns | -12.34 |
|---|---|
| 3M Returns | +23.52 |
| 6M Returns | +56.38 |
| 1Y Returns | +88.05 |
| 5Y Returns | +199.26 |
| 10Y Returns | +336.39 |
Glaukos Corporation Fundamentals
| Market Cap | $9.64 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $507.44 M |
| ROE TTM | -0.26 |
| EPS TTM | $-3.26 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 14.10 |
| EBITDA | $-161.51 M |
| Profit Margin | -36.99 |
| Market Cap | $9.64 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $507.44 M |
| ROE TTM | -0.26 |
| EPS TTM | $-3.26 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 14.10 |
| EBITDA | $-161.51 M |
| Profit Margin | -36.99 |
Glaukos Corporation Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $106.66 M | $124.12 M | $133.54 M | $143.12 M | $150.57 M | $185.61 M |
| Gross Profit + | $82.35 M | $97.22 M | $104.71 M | -$1.52 M | $117.23 M | $151.59 M |
| Operating Income | -$20.68 M | -$22.69 M | -$16.36 M | -$139.87 M | -$19.86 M | -$17.27 M |
| EBITDA | -$12.45 M | -$14.12 M | -$7.23 M | -$127.70 M | -$8.06 M | -$8.40 M |
| Interest Expense | -$1.16 M | -$1.15 M | -$1.18 M | -$1.15 M | -$1.13 M | -$1.46 M |
| Depreciation | $8.23 M | $8.57 M | $9.13 M | $12.16 M | $11.80 M | $8.87 M |
| Income Before Tax | -$17.82 M | -$19.41 M | -$16.00 M | -$139.82 M | -$19.30 M | -$17.72 M |
| Income Tax Expense | $326.00 K | $248.00 K | $234.00 K | -$6.16 M | $484.00 K | $656.00 K |
| Net Income + | -$18.15 M | -$19.66 M | -$16.23 M | -$133.66 M | -$19.78 M | -$18.38 M |
| Net Profit Margin | -17.01% | -15.84% | -12.15% | -93.39% | -13.14% | -9.9% |
Glaukos Corporation Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $57.00 K | $57.00 K | $57.00 K | $58.00 K | $58.00 K | $59.00 K |
| Reserve & Surplus | -$760.98 M | -$780.37 M | -$796.41 M | -$929.83 M | -$950.27 M | -$968.91 M |
| Non-Current Liabilities | $133.69 M | $142.71 M | $142.32 M | $136.06 M | $132.98 M | $135.71 M |
| Current Liabilities | $68.53 M | $79.14 M | $87.52 M | $101.28 M | $89.42 M | $102.33 M |
| Total Liabilities | $202.22 M | $221.85 M | $229.84 M | $237.33 M | $222.40 M | $238.03 M |
| Fixed Assets | $354.68 M | $382.31 M | $375.08 M | $255.17 M | $245.46 M | $239.26 M |
| Current Assets | $444.54 M | $436.06 M | $454.77 M | $474.98 M | $485.75 M | $515.78 M |
| Total Assets | $966.18 M | $986.96 M | $999.38 M | $893.49 M | $893.33 M | $920.52 M |
Glaukos Corporation Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$18.15 M | -$19.66 M | -$16.23 M | -$133.66 M | -$19.78 M | -$18.38 M |
| Operating Cash Flow | -$18.52 M | $6.98 M | -$10.09 M | $6.84 M | -$12.53 M | $14.82 M |
| Investing Cash Flow | -$36.95 M | -$20.78 M | -$3.99 M | -$15.89 M | $10.50 M | -$5.31 M |
| Financing Cash Flow | $1.95 M | $2.25 M | $5.26 M | $2.43 M | $15.77 M | $991.00 K |
| Change in Cash | -$55.37 M | -$14.34 M | -$2.57 M | -$7.43 M | $13.44 M | $9.52 M |
Glaukos Corporation Return Calculator
The Glaukos Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$29,896
Invested Amount$10,000
Est. Returns$19,896
About Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Popular Stocks
FAQs
What is the share price of Glaukos Corporation today?
Glaukos Corporation (GKOS) share price as of September 18, 2026 is $161.26. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Glaukos Corporation?
Yes, Indian Investors can invest in the Glaukos Corporation (GKOS) Share by opening an international trading account with Angel One.
How can I purchase Glaukos Corporation shares in India?
Purchasing Glaukos Corporation (GKOS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Glaukos Corporation (GKOS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Glaukos Corporation?
Yes, you can purchase fractional shares of Glaukos Corporation (GKOS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Glaukos Corporation?
The market capitalization of Glaukos Corporation on September 18, 2026, is $9.64 B.
In which sector Glaukos Corporation belongs?
Glaukos Corporation operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Glaukos Corporation stocks?
In order to invest in Glaukos Corporation (GKOS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
